Francesco Lami, MD, born in Milan in 1960, graduated with full honours in Medicine and Surgery at the State University of Milan. In 1987 he joined the international pharma business and has since then been working in Italian companies with increasing responsibilities and areas of management. In his career, during the past 29 years, he worked for Recordati International and Italfarmaco SpA in a number of different functions and responsibilities at Executive level both at the Headquarters and in affiliate companies where he has been Member of the Board. In 1996 he has been a co-founder of Nicox SA.
Francesco has a deep and recognized knowledge in the fields of BD&L, M&A and Marketing in the European and as well as in the African, Asiatic and ME markets and has a wide network of relationships in the USA and in Japan.
Michele Garufi, Pharm D, Chairman and CEO, co-founded Nicox in 1996, with the goal of addressing innovative therapies based on nitric oxide (NO) donation to patients and doctors. Since then, Nicox has developed a world-leading position in Nitric Oxide donation research. The Company is now focusing its activities in the ophthalmic field, with several promising NO-donating compounds in its pipeline.
Michele, born in 1954 in Milano, Italy, graduated with full honors in Pharmaceutical Chemistry from the University of Milan in 1977 and obtained as well a Pharmacist Degree in 1989.
Michele has extensive experience in partnerships development, licensing agreements and international marketing in the European pharmaceutical industry. In his career he also served as a Board member for Novuspharma Srl, Novexel SA, and he was co-founder and Board member of Scharper SpA, of Delife Srl and of Relivia Srl all successfully sold to Pharma Specialty Companies. Presently, he is a Board member and shareholder of OncoBiotek, a French company active in cancer treatments for dogs, and of Novaera srl, an Italian private Dermatology Research Company.
Franco Merckling, PhD. accomplished biopharmaceutical executive with more than 20 years of successful commercial and General Management experience with leading pharmaceutical companies (Lilly, Merck and Eisai) and Biotech Start Up companies (Kenta, Immodulon). Successful planning and execution of major corporate development projects (Therametrics, Rentschler, Sanochemia), extensive experience in both start-up and change management. Franco holds a PhD degree in Chemistry from the University of Zurich.
Franco has successfully planned and implemented company startup ventures (Greenfield), company asset sale transactions, global restructuring projects, divisions’ spin-off projects (complete manufacturing site) as well as financing & capital increase transactions.